Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Espen Molden

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 28, 2011
[Interactions between metoprolol and antidepressants]Espen Molden, Olav Spigset
Clinical Pharmacology and Therapeutics|July 9, 2005
Celecoxib is often combined with cytochrome P450 2D6 substrates in general clinical practiceEspen Molden, Pia Braathen
Frontiers in Pharmacology|May 10, 2021
<i>CYP2D6</i> Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in PsychiatryEspen Molden, Marin M Jukić
Pharmacotherapy|March 27, 2007
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patientsEspen Molden, Kirsti Svendsen Andersson
British Journal of Clinical Pharmacology|March 24, 2024
Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and responseMagnus Ingelman-Sundberg, Espen Molden
Drug Safety|June 19, 2008
Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitorsEspen Molden, Eva Skovlund, Pia Braathen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4Espen Molden, Anders Asberg, Hege Christensen
British Journal of Clinical Pharmacology|March 15, 2011
The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapineTore Haslemo, Helge Refsum, Espen Molden
Therapeutic Drug Monitoring|April 4, 2023
Impact of CYP2D6 Genotype on Paroxetine Serum ConcentrationKristine Hole, Tore Haslemo, Espen Molden
The Annals of Pharmacotherapy|June 15, 2007
Probable warfarin-simvastatin interactionTone Westergren, Peder Johansson, Espen Molden
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 28, 2011
[Interactions between metoprolol and antidepressants]Espen Molden, Olav Spigset
Clinical Pharmacology and Therapeutics|July 9, 2005
Celecoxib is often combined with cytochrome P450 2D6 substrates in general clinical practiceEspen Molden, Pia Braathen
Frontiers in Pharmacology|May 10, 2021
<i>CYP2D6</i> Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in PsychiatryEspen Molden, Marin M Jukić
Pharmacotherapy|March 27, 2007
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patientsEspen Molden, Kirsti Svendsen Andersson
British Journal of Clinical Pharmacology|March 24, 2024
Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and responseMagnus Ingelman-Sundberg, Espen Molden
Drug Safety|June 19, 2008
Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitorsEspen Molden, Eva Skovlund, Pia Braathen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4Espen Molden, Anders Asberg, Hege Christensen
British Journal of Clinical Pharmacology|March 15, 2011
The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapineTore Haslemo, Helge Refsum, Espen Molden
Therapeutic Drug Monitoring|April 4, 2023
Impact of CYP2D6 Genotype on Paroxetine Serum ConcentrationKristine Hole, Tore Haslemo, Espen Molden
The Annals of Pharmacotherapy|June 15, 2007
Probable warfarin-simvastatin interactionTone Westergren, Peder Johansson, Espen Molden
Pageof 21